Koyfin Home > Directory > Health Care > Oxford Immunotec > Total Debt / Equity

Oxford Immunotec Total Debt / Equity Chart (OXFD)

Oxford Immunotec annual/quarterly Total Debt / Equity from 2012 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Oxford Immunotec Total Debt / Equity for the quarter ending September 09, 2020 was $5m a 12.51% increase of 1m year over year
  • Oxford Immunotec Total Debt / Equity for the last 12 months ending September 09, 2020 was $5m a 12.51% increase of 1m year over year
  • Oxford Immunotec Annual Total Debt / Equity for 2019 was $4m a 97.82% increase of 4m from 2018
  • Oxford Immunotec Annual Total Debt / Equity for 2018 was $0m a -38,195.85% decrease of -34m from 2017
  • Oxford Immunotec Annual Total Debt / Equity for 2017 was $34m a -19.10% decrease of -7m from 2016
Other Ratios Metrics:
  • Oxford Immunotec Total Debt / Capital for the quarter ending September 09, 2018 was $30m a 13.93% increase of 4m year over year
  • Oxford Immunotec Other Liabilities for the quarter ending September 09, 2018 was $4m a -3.83% decrease of 0m year over year
View Chart On Koyfin

Quarterly OXFD Total Debt / Equity Data

09/2020$5m
06/2020$4m
03/2020$4m
12/2019$4m
09/2019$4m
06/2019$4m
03/2019$4m
12/2018$0m
09/2018$42m
06/2018$41m

Annual OXFD Total Debt / Equity Data

2019$4m
2018$0m
2017$34m
2016$41m
2015$1m
2014$1m
2013$1m
2012$10m
2011$3m